Clinical Trial Detail

NCT ID NCT02919449
Title Trial of Measles Virotherapy in Combination With Atezolizumab in Patients With Metastatic Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vyriad, Inc.
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + MV-NIS

Age Groups: adult senior

No variant requirements are available.